Pharmaceutical Research

, Volume 22, Issue 11, pp 1879–1886

Insulin Containing Nanocomplexes Formed by Self-Assembly from Biodegradable Amine-Modified Poly(Vinyl Alcohol)-Graft-Poly(l-Lactide): Bioavailability and Nasal Tolerability in Rats

  • Michael Simon
  • Matthias Wittmar
  • Thomas Kissel
  • Thomas Linn
Research Paper

Purpose

The bioavailability and local tolerability of insulin containing nanocomplexes from amine-modified poly(vinyl alcohol)-graft-poly(l-lactide) were studied in rats. Histology of the nasal epithelium was studied to document integrity of the mucosa.

Methods

Nanocomplexes (NC) were prepared by spontaneous self-assembly of insulin and the water-soluble amphiphilic polymer. Changes in blood glucose and insulin blood concentration were monitored in anesthetized rats using a glucose meter and enzyme-linked immunosorbent assay, respectively. Histological sections of the nasal cavity were examined after H&E staining by light microscopy.

Results

NC reduced blood glucose level in fasted healthy rats by 20% after 50–80 min and in streptozotocin induced diabetic rats by 30% within 75–95 min compared to basal levels. In both animal models significant concentrations of human insulin were detected, with relative bioavailabilities Frel of 2.8 up to 8.3%. The more hydrophobic, lactic acid grafted polyester were more effective at a threefold higher polymer concentration, increasing the relative bioavailability Frel of a 5 IU/kg dose from 2.8 to 5.7%. Histological examination of the nasal mucosa after 4 h showed no signs of toxicity at the site of nasal administration.

Conclusions

These results demonstrate that the NC significantly enhanced insulin absorption, suggesting that amphiphilic biodegradable comb-polymers offer a promising approach for nasal peptide delivery.

Key Words

bioavailability in rats insulin nanocomplexes nasal administration nasal carrier nasal histology 

References

  1. 1.
    Andersson, L., Blomberg, L., Flegel, M., Lepsa, L., Nilsson, B., Verlander, M. 2000Large-scale synthesis of peptidesBiopolymers55227250CrossRefPubMedGoogle Scholar
  2. 2.
    Pontiroli, A. E. 1998Peptide hormones: review of current and emerging uses by nasal deliveryAdv. Drug Deliv. Rev.298187CrossRefPubMedGoogle Scholar
  3. 3.
    Chetty, D. J., Chien, Y. W. 1998Novel methods of insulin delivery: an updateCrit. Rev. Ther. Drug Carrier Syst.15629670PubMedGoogle Scholar
  4. 4.
    Simon, M., Kissel, T. 2001Away with the needle. Noninvasive administration routes for insulin: improved quality of life for diabeticsPharm. Unserer Zeit30136141CrossRefPubMedGoogle Scholar
  5. 5.
    Gizurarson, S., Bechgaard, E. 1991Study of nasal enzyme activity towards insulin. In vitroChem. Pharm. Bull.3921552157PubMedGoogle Scholar
  6. 6.
    Deurloo, M. J., Hermens, W. A., Romeyn, S. G., Verhoef, J. C., Merkus, F. W. 1989Absorption enhancement of intranasally administered insulin by sodium taurodihydrofusidate (STDHF) in rabbits and ratsPharm. Res.6853856CrossRefPubMedGoogle Scholar
  7. 7.
    Hinchcliffe, M., Illum, L. 1999Intranasal insulin delivery and therapyAdv. Drug Deliv. Rev.35199234CrossRefPubMedGoogle Scholar
  8. 8.
    Sanchez, A., Ygartua, P., Fos, D. 1991Role of surfactants in the bioavailability of intranasal insulinEur. J. Drug Metab. Pharmacokinet.3120124Google Scholar
  9. 9.
    Chandler, S. G., Illum, L., Thomas, N. W. 1991Nasal absorption in the rats: II. Effect of enhancers on insulin absorption and nasal histologyInt. J. Pharm.766170CrossRefGoogle Scholar
  10. 10.
    Prego, C., Garcia, M., Torres, D., Alonso, M. J. 2005Transmucosal macromolecular drug deliveryJ. Control. Release101151162CrossRefPubMedGoogle Scholar
  11. 11.
    Koping-Hoggard, M., Sanchez, A., Alonso, M. J. 2005Nanoparticles as carriers for nasal vaccine deliveryExpert Rev. Vaccines4185196CrossRefPubMedGoogle Scholar
  12. 12.
    Fernandez-Urrusuno, R., Calvo, P., Remunan-Lopez, C., Vila-Jato, J. L., Alonso, M. J. 1999Enhancement of nasal absorption of insulin using chitosan nanoparticlesPharm. Res.1615761581CrossRefPubMedGoogle Scholar
  13. 13.
    Brooking, J., Davis, S. S., Iluum, L. 2001Transport of nanoparticles across the rat nasal mucosaJ. Drug Target.9267279PubMedGoogle Scholar
  14. 14.
    Vila, A., Sanchez, A., Evora, C., Soriano, I., McCallion, O., Alonso, M. J. 2005PLA–PEG particles as nasal protein carriers: the influence of the particle sizeInt. J. Pharm.2924352CrossRefPubMedGoogle Scholar
  15. 15.
    Takeuchi, H., Yamamoto, H., Kawashima, Y. 2001Mucoadhesive nanoparticulate systems for peptide drug deliveryAdv. Drug Deliv. Rev.473954CrossRefPubMedGoogle Scholar
  16. 16.
    Dondeti, P., Zia, H., Needham, T. 1996Bioadhesive and formulation parameters affecting nasal absorptionInt. J. Pharm.127115133CrossRefGoogle Scholar
  17. 17.
    Jimenez-Castellanos, M. R., Zia, H., Rhodes, C. T. 1993Mucoadhesive drug delivery systemsDrug Dev. Ind. Pharm.19143194Google Scholar
  18. 18.
    Granger, D. N., Kvielys, P. R., Perry, M. A., Taylor, A. E. 1986Charge selectivity of rat intestinal capillaries—influence of polycationsGastroenterology9114431446PubMedGoogle Scholar
  19. 19.
    Maitani, Y., Machida, Y., Nagai, T. 1992Influence of molecular weight and charge on nasal absorption of dextran and DEAE-dextran in rabbitsInt. J. Pharm.764349Google Scholar
  20. 20.
    Illum, L., Farraj, N. F., Davis, S. S. 1994Chitosan as novel nasal delivery system for peptide drugsPharm. Res.1111861189CrossRefPubMedGoogle Scholar
  21. 21.
    Fernandez-Urrusuno, R., Calvo, P., Remunan-Lopez, C., Vila-Jato, J. L., Alonso, M. J. 1999Enhancement of nasal absorption of insulin using chitosan nanoparticlesPharm. Res.1615761581CrossRefPubMedGoogle Scholar
  22. 22.
    Simon, M., Wittmar, M., Bakowsky, U., Kissel, T. 2004Self-assembling nanocomplexes of insulin and water-soluble branched poly[(vinyl-3-(diethyl amino)propylcarbamate-co-(vinylacetate)-co-(vinyl alcohol)]-graft-poly(D,l-lactid): a novel carrier for transmucosal delivery of peptidesBioconjug. Chem.15841849CrossRefPubMedGoogle Scholar
  23. 23.
    M. Wittmar, Charge modified, comb-like graft-polyesters for drug delivery and DNA vaccination: synthesis and characterization of poly(vinyl dialkylaminoalkylcarbamte-co-vinyl acetate-co-vinyl alcohol)-graft-poly(D,l-lactide-co-glycolide)s, Dissertation, Philipps University Marburg, 2004.http://archiv.ub.uni-marburg.de/diss/z2004/0075/ (accessed 01/13/04).
  24. 24.
    Chandler, S. G., Illum, L., Thomas, N. W. 1991Nasal absorption in the rats: I. A method to demonstrate the histological effects of nasal formulationsInt. J. Pharm.701927CrossRefGoogle Scholar
  25. 25.
    Dailey, L. A., Kleemann, E., Wittmar, M., Gessler, T., Schmehl, T., Roberts, C., Seeger, W., Kissel, T. 2003Surfactant-free, biodegradable nanoparticles for aerosol therapy based on the branched polyesters, DEAPA-PVAL-g-PLGAPharm. Res.2020112020CrossRefPubMedGoogle Scholar
  26. 26.
    Mayor, S. H., Illum, L. 1997Investigation of the effect of anesthesia on nasal absorption of insulin in ratsInt. J. Pharm.149123129CrossRefGoogle Scholar
  27. 27.
    Damge, C., Michel, C., Aprahamian, M., Couvreur, P. 1988New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrierDiabetes37246251PubMedGoogle Scholar
  28. 28.
    Anwana, A. B., Garland, H. O. 1991Intracellular dehydration in the rat made diabetic with streptozotocin: effects of infusionJ. Endocrinol.128333337PubMedGoogle Scholar
  29. 29.
    Yoshida, T., Nishioka, H., Nakamura, Y., Kondo, M. 1985Reduced noradrenalin turnover in streptozotocin-induced diabetic ratsDiabetologia28692696CrossRefPubMedGoogle Scholar
  30. 30.
    Bellush, L. L., Henley, W. N. 1990Altered responses to environmental stress in streptozotocin-diabetic ratsPhysiol. Behav.47231238CrossRefPubMedGoogle Scholar
  31. 31.
    Dyer, A. M., Hinchcliffe, M., Watts, P., Castille, J., Jabbal-Gill, I., Nankervis, R., Smith, A., Illum, L. 2002Nasal delivery of insulin using novel chitosan based formulations: a comparative study in two animal models between simple chitosan formulations and chitosan nanoparticlesPharm. Res.199981008CrossRefPubMedGoogle Scholar
  32. 32.
    Schipper, N. G., Olsson, S., Hoogstraate, J. A., Boer, A. G., Varum, K. M., Artursson, P. 1997Chitosans as absorption enhancers for poorly absorbable drugs 2: mechanism of absorption enhancementPharm. Res.14923929CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science + Business Media, Inc. 2005

Authors and Affiliations

  • Michael Simon
    • 1
  • Matthias Wittmar
    • 1
  • Thomas Kissel
    • 1
  • Thomas Linn
    • 2
  1. 1.Department of Pharmaceutics and BiopharmacyPhilipps UniversityMarburgGermany
  2. 2.Medical Clinic and Policlinic 3Justus-Liebig University GiessenGiessenGermany

Personalised recommendations